It's time for the Lightning Round. Cramer makes the call on viewer favorites.» Read More
THE NETHERLANDS, Netherlands _ Core Laboratories NV on Wednesday reported third-quarter profit of $66.5 million. The The Netherlands, Netherlands- based company said it had profit of $1.50 per share. For the current quarter ending in December, Core Laboratories said it expects revenue in the range of $275 million to $280 million.
In his book "Get Rich Carefully," CNBC's "Mad Money" host explains how spotting long-term megatrends can help investors surf the wave of profitability.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Core Laboratories CEO David Demshur speaks about the company's record earnings data, and says the Sprayberry oil field is the second largest in the world. "Together, Spraberry/Wolfcamp can produce over 50 billion barrels of recoverable oil," he says.
According to Core Labs, new technology will give our nation the world's second largest oil field.
Had you picked stocks thoughtfully and carefully since Mad Money began, you would have beaten the S&P by 3000%!
You probably wouldn’t think of playing the US energy boom with this stock. But Jim Cramer says you should.
Oct 3- Core Laboratories NV:. *Natixis cuts Core Lab price target to $111 from $130; rating neutral. Reuters Station users, click. 1568.
**ARQULE INC, $2.30, down 53.9 pct The biotechnology company and Japan's Daiichi Sankyo Co Ltd. **GENERAL MOTORS, $23.82, up 3 pct. Hedge fund manager David Einhorn said auto-maker General Motors "is much healthier now," and is getting its product refreshments "right."
The Dow and S&P 500 turned negative while the Nasdaq cut its gains in late morning on Tuesday, with materials and energy shares leading declines on the S&P. **ARQULE INC $2.21 down 55.5 pct The biotechnology company and Japan's Daiichi Sankyo Co Ltd. **FORD MOTOR CO, $9.78, down 1.6 pct.
Oct 2- Core Laboratories NV:. *FBR cuts Core Laboratories NV price target to $110 from $133; rating. Reuters Station users, click. 1568.
Take a look at some of Tuesdays morning movers.
Oct 2- Core Laboratories NV:. *Barclays cuts Core Laboratories NV price target to $126 from $137;. Reuters Station users, click. 1568.
Should Core Labs be part of your core holdings? David Demshur, Core Labs CEO, discusses the company's solid quarter and growth opportunities, with Mad Money's Jim Cramer.
Mad Money's Cramer likes the consistent returns on this high tech stock, and drills down to find out more about the company's future in the oil patch, with Dave Demshur, Core Labs president/CEO.
Morgan Stanley will buy the company for $22.80 a share, according to Crescent, which has about 102.8 million shares outstanding.